focus -WSS

focus

author：explore 2025-09-30 20:05:44 - browse：84383

Judge's gavel — Legal experts unpacked the pharmaceutical industry's scattershot approach to challenging Medicare's new power to negotiate drug prices. Adobe

WASHINGTON — The pharmaceutical industry has been filing a lawsuit here, there, and pretty much everywhere.

Drugmakers lost a two-decade long lobbying fight in Congress last summer when Democrats gave Medicare more power to choose what it pays for prescription drugs. Now, they’re taking their battle to the courts.

Merck filed suit in the District of Columbia. Bristol Myers Squibb filed in New Jersey. The Chamber of Commerce filed in Ohio. PhRMA filed in Texas. And there’s no reason to believe the barrage of lawsuits will stop anytime soon.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Sports medicine is finally prioritizing gender equality
Next article： Drugmakers bet big on mRNA for cancer. Why's Biden going in?

hotspot

WSS

As obesity drug market grows, telehealth companies court payers

Lab trade group sues FDA to halt regulation of lab

Merck to buy EyeBio, maker of eye drug, as it grows pipeline

iTeos Therapeutics debuts first data on TIGIT

Health insurers say they are turning to AI to cut costs, improve care

Trump to be booked at notorious Fulton County Jail at center of DOJ probe

entertainment

focus

explore

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Dark money group runs ads on China biotech bill

In Memoriam: Notable people who died in 2023

How the first Native Hawaiian psychiatrist helped diversify medicine

Jerome Adams on the need for new antivirals for Covid

Vivek Ramaswamy made waves in the debate, much as in biotech

How one medical school became remarkably diverse

Former Pear Therapeutics executives start new VC firm

New air purifier tech could be key to improving indoor air quality

Hospital at home shows how to bring innovation to health care

focus

Biohaven protein

Lab trade group sues FDA to halt regulation of lab

People can get long Covid without testing positive for virus: Study

Startling documents reveal new facets of Sacklers' opioid empire

Can U.S. cancer drug shortages be fixed?

Akili, maker of video game for ADHD, to be acquired for 34 million

knowledge

leisure time

hotspot

Wikipedia